A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern. - Wayham NP; Niedecken AR; Simons JF; Chiang YY; Medina-Cucurella AV; Mizrahi RA; Wagner EK; Gras A; Segal I; Witte P; Enstrom A; Bountouvas A; et al. (The Journal of infectious diseases, 2023)